Clinical Significance of Prior Ramucirumab Use on the Effectiveness of Nivolumab as the Third-Line Regimen in Gastric Cancer: A Multicenter Retrospective Study

• Main Authors: Yuka Obayashi (Author), Shoichiro Hirata (Author), Yoshiyasu Kono (Author), Makoto Abe (Author), Koji Miyahara (Author), Masahiro Nakagawa (Author), Michihiro Ishida (Author), Yasuhiro Choda (Author), Kenta Hamada (Author), Masaya Iwamuro (Author), Seiji Kawano (Author), Yoshiro Kawahara (Author), Motoyuki Otsuka (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2024-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background and Objective Because vascular endothelial growth factor inhibition has been suggested to improve immune cell function in the cancer microenvironment, we examined whether using ramucirumab (RAM) before nivolumab usage is more effective in advanced gastric cancer. Methods This was...